Search results
Results from the WOW.Com Content Network
This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.
The Food and Drug Administration (FDA) of the Philippines, formerly the Bureau of Food and Drugs (BFAD / ˈ b iː f æ d /; 1982–2009), is a health regulatory agency under the Department of Health created on 1963 by Republic Act No. 3720, amended on 1987 by Executive Order 175 otherwise known as the "Food, Drugs and Devices, and Cosmetics Act", and subsequently reorganized by Republic Act No ...
FDA-licensed in 1998; Withdrawn in EU (2002), US (2006) Fosamprenavir: HIV ViiV Healthcare: Amprenavir pro-drug: 2003 (FDA), 2004 Foscarnet: Herpes: Pyrophosphate analogue DNA polymerase inhibitor: 1991 Ganciclovir (Cytovene) [9] Cytomegalovirus (CMV) [10] Competitive nucleoside analogue dGTP inhibitor 1988 Ibacitabine: Herpes labialis ...
The IATF-EID convened in January 2020 to address the growing viral outbreak in Wuhan, China. [5] They made a resolution to manage the spreading of the new virus, [5] which was known at the time as 2019 novel coronavirus (2019-nCoV) and eventually renamed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19. [6]
In the United Kingdom, Varilrix, a live viral vaccine [14] is approved from the age of 12 months, but only recommended for certain at risk groups. Minor side effects may include pain at the site of injection, fever, and rash. [9] Severe side effects are rare and occur mostly in those with poor immune function. [10]
(Reuters) -The U.S. Food and Drug Administration has approved Verrica Pharmaceuticals Inc's treatment of a viral skin infection in adults and children aged 2 years and above, the company said on ...
President Duterte during a meeting with members of the IATF-EID at the Matina Enclaves in Davao City in June 2020. The COVID-19 Immunization Program Management Organizational Structure was formed on October 26, 2020, to facilitate the distribution of COVID-19 vaccines in the Philippines, however this was replaced by a vaccine cluster within the Inter-Agency Task Force for the Management of ...
The RITM is tasked by the Philippine Department of Health and the Philippine Government to supervise, plan, and successfully implement research programs to prevent and to control prevailing infectious and tropical diseases in the Philippines. This includes research involving the advancement of vaccines and medications used by medical ...